Home › NDC Lookup › Labelers › Outlook Therapeutics, Inc.

Outlook Therapeutics, Inc. NDCs and Package Codes

This page lists NDC package records associated with labeler code 82491 (Outlook Therapeutics, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

1
Package NDCs
2
Products
2
Active listings
0
Discontinued
1
Ingredients
0
Therapeutic classes
1
Dosage forms
0
With NADAC pricing

Portfolio

Top ingredients
bevacizumab-vikg 2
By dosage form
INJECTION 2

Browse records — 2 products

Drug / product Billing NDC NADAC / unit Status
LYTENAVA bevacizumab-vikg 1.25 mg/1 INJECTION Outlook · NDC 82491-0025-10 · 1 VIAL, GLASS in 1 CARTON (82491-025-10) / 1 INJECTION in 1 VIAL, GLASS 82491-0025-10 — On market View →
LYTENAVA bevacizumab-vikg 1.25 mg/1 INJECTION Outlook · NDC 82491-0025-10 · 1 VIAL, GLASS in 1 CARTON (82491-025-10) / 1 INJECTION in 1 VIAL, GLASS 82491-0025-10 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.